Factor v Leiden and prothrombin G20210A polymorphisms are not associated with disease-free survival in breast cancer

Breast Cancer Research and Treatment

Volumn 116, Issue 3, 2009, Pages 619-620

  Eroglu, Aydan ^a   Çam, Ragip ^a   Eğin, Yonca ^a   Akar, Nejat ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; BLOOD CLOTTING FACTOR 5 LEIDEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GENOMIC DNA; GUANOSINE; PROTHROMBIN; BLOOD CLOTTING FACTOR 5;

BREAST CANCER; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME; BREAST TUMOR; FEMALE; FOLLOW UP; GENETICS; PATHOLOGY; SURVIVAL RATE; TUMOR RECURRENCE;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FACTOR V; FEMALE; FOLLOW-UP STUDIES; HUMANS; NEOPLASM RECURRENCE, LOCAL; POLYMORPHISM, GENETIC; PROTHROMBIN; SURVIVAL RATE;

EID: 70349564128     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0177-0     Document Type: Letter

References (10)

1. Winter PC (2006) The pathogenesis of venous thromboembolism in cancer: emerging links with tumor biology. Hematol Oncol 24:126-133. doi:10.1002/hon.785
2. Paspatis GA, Sfyridaki A, Papanikolaou N, Triantafyllou K, Livadiotaki A, Kapsoritakis A et al (2002) Resistance to activated protein C, factor V Leiden and prothrombin G20210A variant in patients with colorectal cancer. Pathophysiol Haemost Thromb 32:2-7. doi:10.1159/000057282
3. Samonakis DN, Koutroubakis IE, Sfiridaki A, Malliaraki N, Antoniou P, Romanos J et al (2004) Hypercoagulable states in patients with hepatocellular carcinoma. Dig Dis Sci 49:854-858. doi:10.1023/B:DDAS.0000030099.13397.28
4. Vairaktaris E, Yapijakis C, Wiltfang J, Ries J, Vylliotis A, Derka S et al (2005) Are factor V and prothrombin mutations associated with increased risk of oral cancer? Anticancer Res 25:2561-2565
5. Battistelli S, Stefanoni M, Genovese A, Vittoria A, Cappelli R, Roviello F (2006) Prevalence of factor V Leiden and prothrombin G20210A in patients with gastric cancer. World J Gastroenterol 12:4179-4180
6. Tormene D, Beltramello P, Perlati M, Brandolin B, Barbar S, De Toffoli G, Simioni P (2008) The risk of cancer progression in women with gynecological malignancies and thrombophilic polymorphisms: a pilot case-control study. Clin Appl Thromb Hemost (Epub ahead of print). doi: 10.1177/1076029608317941
7. Pihusch R, Danzl G, Scholz M, Harich D, Pihusch M, Lohse P et al (2002) Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma. Cancer 94:3120-3126. doi:10.1002/cncr.10590
8. Brüggemann LW, Versteeg HH, Niers TM, Reitsma PH, Spek CA (2008) Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders. J Cell Mol Med (Epub ahead of print)
9. Klerk CPW, Smorenburg SM, Spek CA, Van Noorden CJF (2007) Colon cancer metastasis in mouse liver is not affected by hypercoagulability due to Factor V Leiden mutation. J Cell Mol Med 11:561-568. doi:10.1111/j.1582-4934.2007.00046.x
10. Eroglu A, Ulu A, Cam R, Kurtman C, Akar N (2007) Prevalence of factor V 1691G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients. J Thromb Thrombolysis 23:31-34. doi:10.1007/s11239-006-9001-z